Singapore biotherapeutics firm Hummingbird bags $125m in series C round

May 18, 2021 | Funding




The new capital will be used to develop precision therapeutics for the treatment of multiple myeloma.



Source link

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.